it will probably be cheaper to get approval in Europe than going for rosacea or MRSA to gain more revenue but I'm here for the long term so as long as they are still moving forward I'm happy
- Forums
- ASX - By Stock
- BOT
- Ann: March 2023 Quarterly Activities Report and Appendix 4C
Ann: March 2023 Quarterly Activities Report and Appendix 4C, page-33
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
42.0¢ |
Change
0.005(1.20%) |
Mkt cap ! $766.4M |
Open | High | Low | Value | Volume |
41.0¢ | 42.5¢ | 41.0¢ | $1.198M | 2.855M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 463055 | 41.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
42.5¢ | 837154 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 462955 | 0.415 |
10 | 704332 | 0.410 |
16 | 690592 | 0.405 |
16 | 729758 | 0.400 |
13 | 1040097 | 0.395 |
Price($) | Vol. | No. |
---|---|---|
0.425 | 837154 | 11 |
0.430 | 419620 | 19 |
0.435 | 134653 | 7 |
0.440 | 455971 | 8 |
0.445 | 92095 | 3 |
Last trade - 12.49pm 06/09/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |